![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » MAJOR MEDICAL DEVICE MANUFACTURERS SEE TREATMENT OF PERIPHERAL VASCULAR DISEASES AS MAJOR REVENUE GROWTH GENERATOR
MAJOR MEDICAL DEVICE MANUFACTURERS SEE TREATMENT OF PERIPHERAL VASCULAR DISEASES AS MAJOR REVENUE GROWTH GENERATOR
Stenting and stent graft procedures are now transitioning into the gold standard form of treatment for combating peripheral vascular diseases (PVD). An underserved
market with high rates of disability and morbidity, PVD represents a significant
market opportunity for medical stent manufacturers. Since the industry requires
specialized devices to address the vast intricacies of the peripheral vasculature,
market participants have the prospect to utilize their versatile expertise in
design and development. The stellar clinical success and titanic revenue streams
generated by the coronary stent market have sparked significant interest in
their sister devices.
Yahoo
News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct